AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00759-06v1
50/12/4174    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Co, E.-M. A.
Right arrow Articles by Schiller, N. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Co, E.-M. A.
Right arrow Articles by Schiller, N. L.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2006, p. 4174-4176, Vol. 50, No. 12
0066-4804/06/$08.00+0     doi:10.1128/AAC.00759-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Resistance Mechanisms in an In Vitro-Selected Amoxicillin-Resistant Strain of Helicobacter pylori{triangledown}

Edgie-Mark A. Co and Neal L. Schiller*

Biomedical Sciences Division, University of California, Riverside, Riverside, California 92521

Received 22 June 2006/ Returned for modification 25 August 2006/ Accepted 14 September 2006


   ABSTRACT
Top
 Abstract
Text
 References
 
We investigated the ß-lactam resistance mechanism(s) of an in vitro-selected amoxicillin-resistant Helicobacter pylori strain (AmoxR). Our results demonstrated that resistance is due to a combination of amino acid substitutions in penicillin binding protein 1 (PBP1), HopB, and HopC identified in AmoxR, resulting in decreased affinity of PBP1 for amoxicillin and decreased accumulation of penicillin.


   TEXT
Top
 Abstract
 Text
References
 
Helicobacter pylori is the most common cause of gastric and duodenal ulcers and is strongly associated with the development of gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma (4). Treatment of H. pylori infection typically employs a triple-drug regimen using two antibiotics and a proton pump inhibitor or bismuth (4). However, resistance to the most commonly used antibiotics has already been observed worldwide (3, 8).

In a previous study (1), we isolated an amoxicillin-resistant mutant strain of H. pylori 43579 (designated AmoxR) with a MIC of 4 to 8 µg/ml by progressively culturing an amoxicillin-susceptible strain (AmoxS; MIC, 0.03 to 0.06 µg/ml) in increasing amounts of amoxicillin. The penicillin binding protein (PBP) profile of this strain showed a decreased affinity of PBP1 for amoxicillin, and AmoxR demonstrated a decrease in 14C-labeled penicillin G accumulation (1). In this study, we report the presence of pbp1 and hop mutations in the in vitro-selected amoxicillin-resistant mutant AmoxR and determine their effects on amoxicillin susceptibility.

The pbp1 genes from AmoxS and AmoxR were amplified by PCR using primer sequences derived from the published 26695 sequence (12). The PCR products were sequenced at the University of California (UC), Riverside, Genomics Institute, and sequence alignment was performed in Sequencher (Gene Codes Corporation, Ann Arbor, MI). Comparison of the two pbp1 sequences revealed a threonine-to-methionine conversion in the 438th amino acid position of PBP1 in AmoxR, located adjacent to an SLN motif, one of the penicillin binding domains (7). Others have also identified mutations localized around the SKN, SNN, and KTG motifs (7), which may be involved in ß-lactam resistance (6, 9, 10, 11). To characterize the effect of this single T438M mutation in PBP1 on amoxicillin resistance, the gene was introduced into the well-characterized amoxicillin-susceptible (MIC, 0.06 µg/ml) H. pylori strain 700392, using electroporation as described by Wang et al. (13). Transformant selection was performed by plating electroporated cells onto brucella agar plates containing 5% sheep blood and amoxicillin at various concentrations. Several transformants (including PBP1-T) were randomly selected and found to have MICs for amoxicillin of 0.5 µg/ml, an eightfold increase compared to the parental strain (Table 1). Amplification and sequencing of the pbp1 gene from PBP1-T confirmed that the transformant possessed the mutant pbp1 from AmoxR. PBP1-T also had comparably increased MICs for ampicillin and penicillin G, although little or no increase in MIC levels was noted for the other ß-lactams examined, suggesting that this particular pbp1 mutation in AmoxR affects the binding affinity of PBP1 for only a few specific antibiotics.


View this table:
[in this window]
[in a new window]
  		TABLE 1. MICs of each ß-lactam antibiotic for H. pylori 700392 and various transformantsa

 
To compare the affinity of PBP1 for amoxicillin in 700392 and PBP1-T, we titrated the binding of PBP1 using biotinylated amoxicillin (bio-Amox) as described previously (1). In this study, equivalent amounts of membrane proteins were labeled for 10 min at room temperature with bio-Amox concentrations ranging from 0.001 to 2 µg/ml. At very low to moderate amoxicillin concentrations, the PBP1 in PBP1-T bound substantially less amoxicillin than the PBP1 in the susceptible parental strain (Fig. 1); it required more than eight times as much bio-Amox to achieve equivalent binding of PBP1 in PBP1-T as in 700392. Interestingly, the saturation of PBP1 with bio-Amox in both strains occurred at concentrations near their respective MICs (Fig. 1B). For strain 700392, saturation binding started between 0.05 and 0.1 µg/ml (MIC = 0.06), while in the transformant PBP1-T, saturation binding occurred at 0.8 µg/ml (MIC = 0.5). These data suggest a possible correlation between the degree of amoxicillin binding and the level of susceptibility to amoxicillin.


Figure 1
View larger version (39K):
[in this window]
[in a new window]
  		FIG. 1. (A) Bio-Amox labeling of 700392 and PBP1-T PBPs. Equivalent amounts of membrane proteins were exposed to increasing amounts of bio-Amox to saturation. The numbers indicate bio-Amox concentrations (µg/ml) used to label PBP1. The arrows indicate the locations of the PBP1 band; the two lower bands correspond to PBP2 and PBP3. (B) Quantitative densitometric tracings of PBP1 bands. The data represent the means ± standard deviations based on four separate experiments (including the gel shown in panel A).

 
In our previous study, AmoxR accumulated >40% less 14C-labeled penicillin G than equal numbers of AmoxS bacteria (1). Since decreased permeability of antibiotics through the outer membrane of AmoxR could account for the lower accumulation of 14C-labeled penicillin G, we focused on H. pylori porin proteins (2, 5, 12). Sequence alignments of the genes hopA, hopD, and hopE from AmoxR, compared to their parental counterparts in AmoxS, did not reveal any amino acid substitutions. On the other hand, the hopB gene of AmoxR possesses a number of mutations localized in the amino acid 116 to 201 region, and the hopC gene possesses a stop codon at the 211th amino acid position (data not shown). When these genes were transformed into 700392, the resulting strains were observed to have increased MICs for amoxicillin of 0.25 µg/ml for HopB-T and 0.125 µg/ml for HopC-T (Table 1). When the MICs for other antibiotics were tested, both transformants had elevated MICs for ampicillin and penicillin G but little or no increase for the other ß-lactams tested.

Subsequent experiments revealed decreased 14C-labeled penicillin G accumulation in the hop mutants, approximately 20% and 10% less than that in the parental strain for HopB-T and HopC-T, respectively, after 60 min of incubation. The most dramatic decrease was observed at the 15-min time point, when ~30% less 14C-labeled penicillin G had accumulated in both strains (Fig. 2).


Figure 2
View larger version (8K):
[in this window]
[in a new window]
  		FIG. 2. 14C-labeled penicillin G accumulation of H. pylori 700392 and hop transformants. Log-phase cultures were incubated with 14C-labeled penicillin G, and 1-ml aliquots were taken at 15, 30, 45, and 60 minutes, centrifuged, and washed, and radioactivity was measured in a scintillation counter. The error bars represent the means ± standard errors of the means based on three separate experiments.

 
Double mutants possessing pbp1-T438M and altered hop genes were constructed and showed increased MICs for all ß-lactams tested in an additive fashion, particularly the PBP1-T/HopB mutant (Table 1), indicating that the PBP1 and HopB alterations work in concert to decrease the effectiveness of the antibiotics. When both hop genes were transformed into PBP1-T, creating a triple mutant, a further decrease in 14C-labeled penicillin G accumulation (Fig. 2), as well as a concurrent increase in the MIC, was observed (Table 1). The MIC level for amoxicillin observed in the triple mutant was 4 µg/ml, comparable to that seen in AmoxR (4 to 8 µg/ml). In addition, the 14C-labeled penicillin G accumulation levels in this triple mutant reflected about a 40% decrease compared to the parental strain at the 60-min time point (Fig. 2), comparable to that observed with AmoxR (1). These experiments suggest that the amino acid substitutions affecting PBP1, HopB, and HopC account for all the resistance mechanisms found in AmoxR.


   ACKNOWLEDGMENTS
 
This research was supported in part by grants from UC MEXUS and the UC Cancer Research Coordinating Committee. E.-M. A. Co acknowledges support provided by a Graduate Division Dissertation Grant at UCR.


   FOOTNOTES
 
* Corresponding author. Mailing address: Biomedical Sciences Division, University of California, Riverside, Riverside, CA 92521-0121. Phone: (951) 827-4535. Fax: (951) 827-5504. E-mail: neal.schiller{at}ucr.edu. Back

{triangledown} Published ahead of print on 25 September 2006. Back


   REFERENCES
Top
 Abstract
 Text
 References
 

  1. DeLoney, C. R., and N. L. Schiller. 2000. Characterization of an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori. Antimicrob. Agents Chemother. 44:3368-3373.[Abstract/Free Full Text]
  2. Doig, P., M. M. Exner, R. E. W. Hancock, and T. J. Trust. 1995. Isolation and characterization of a conserved porin protein from Helicobacter pylori. J. Bacteriol. 177:5447-5452.[Abstract/Free Full Text]
  3. Duck, W. M., J. Sobel, J. M. Pruckler, Q. Song, D. Swedlow, C. Friedman, A. Sulka, B. Swaminathan, T. Taylor, M. Hoekstra, P. Griffin, D. Smoot, R. Peek, D. C. Metz, P. B. Bloom, S. Goldschmid, J. Parsonnet, G. Triadafilopoulos, G. I. Perez-Perez, N. Vakil, P. Ernst, S. Czinn, D. Dunne, and B. D. Gold. 2004. Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg. Infect. Dis. 10:1088-1094.[Medline]
  4. Dunn, B. E., H. Cohen, and M. J. Blaser. 1997. Helicobacter pylori. Clin. Microbiol. Rev. 10:720-741.[Abstract]
  5. Exner, M. M., P. Doig, T. J. Trust, and R. E. W. Hancock. 1995. Isolation and characterization of a family of porin proteins from Helicobacter pylori. Infect. Immun. 63:1567-1572.[Abstract]
  6. Gerrits, M. M., D. Schuijffel, A. A. van Zwet, E. J. Kuipers, C. M. J. E. Vanderbrouke-Grauls, and J. G. Kursters. 2002. Alterations in penicillin-binding protein 1A confer resistance to ß-lactam antibiotics in Helicobacter pylori. Antimicrob. Agents Chemother. 46:2229-2233.[Abstract/Free Full Text]
  7. Harris, A. G., S. L. Hazell, and A. G. Netting. 2000. Use of digoxigenin-labelled ampicillin in the identification of penicillin-binding proteins in Helicobacter pylori. J. Antimicrob. Chemother. 45:591-598.[Abstract/Free Full Text]
  8. Kursters, J. G., and E. J. Kuipers. 2001. Antibiotic resistance of Helicobacter pylori. J. Appl. Microbiol. 90:134s-144s.[CrossRef]
  9. Kwon, D. H., M. P. Dore, J. J. Kim, M. Kato, M. Lee, J. Y. Wu, and D. Y. Graham. 2003. High-level ß-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 47:2169-2178.[Abstract/Free Full Text]
  10. Okamoto, T., H. Yoshiyama, T. Nakazawa, I.-D. Park, M.-W. Chang, H. Yanai, K. Okita, and M. Shirai. 2002. A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori. J. Antimicrob. Chemother. 50:849-856.[Abstract/Free Full Text]
  11. Paul, R., S. Postius, K. Melchers, and K. P. Schafer. 2001. Mutations of the Helicobacter pylori genes rdxA and pbp1 cause resistance against metronidazole and amoxicillin. Antimicrob. Agents Chemother. 45:962-965.[Abstract/Free Full Text]
  12. Tomb, J.-F., O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton, R. D. Fleischmann, K. A. Ketchum, H. P. Klenk, S. Gill, B. A. Dougherty, K. Nelson, J. Quakenbush, L. Zhou, E. F. Kirkness, S. Peterson, B. Loftus, D. Richardson, R. Dodson, H. G. Khalak, A. Glodek, K. McKenney, L. M. Fitzgerald, N. Lee, M. D. Adams, E. K. Hickey, D. E. Berg, J. D. Gocayne, T. R. Utterback, J. D. Peterson, J. M. Kelley, M. D. Cotton, J. M. Weidman, C. Fujii, C. Bowman, L. Watthey, E. Wallin, W. S. Hayes, M. Borodovsky, P. D. Karp, H. O. Smith, C. M. Fraser, and J. C. Venter. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539-553.[CrossRef][Medline]
  13. Wang, Y., K. P. Roos, and D. E. Taylor. 1993. Transformation of Helicobacter pylori by chromosomal metronidazole resistance and by a plasmid with a selectable chloramphenicol resistance marker. J. Gen. Microbiol. 139:2485-2493.[Medline]

Antimicrobial Agents and Chemotherapy, December 2006, p. 4174-4176, Vol. 50, No. 12
0066-4804/06/$08.00+0     doi:10.1128/AAC.00759-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00759-06v1
50/12/4174    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Co, E.-M. A.
Right arrow Articles by Schiller, N. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Co, E.-M. A.
Right arrow Articles by Schiller, N. L.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS